Herantis Pharma Oyj
HRPMF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $68 | $55 | $48 | $31 |
| - Cash | $1 | $6 | $5 | $6 |
| + Debt | $0 | $0 | $5 | $5 |
| Enterprise Value | $68 | $49 | $48 | $31 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$5 | $1 | $8 | $7 |
| % Margin | – | – | – | – |
| Net Income | -$5 | $0 | -$9 | -$24 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.24 | 0.016 | -0.64 | -2.2 |
| % Growth | -1,572.4% | 102.5% | 70.9% | – |
| Operating Cash Flow | -$7 | -$5 | -$9 | -$10 |
| Capital Expenditures | $0 | $0 | $0 | $0 |
| Free Cash Flow | -$7 | -$5 | -$9 | -$10 |